enzastaurin has been researched along with Leukemia, Myeloid, Acute in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aiche, S; Bassermann, F; Becker, W; Canevari, G; Casale, E; Depaolini, SR; Ehrlich, HC; Felder, ER; Feuchtinger, A; Garz, AK; Gohlke, BO; Götze, K; Greif, PA; Hahne, H; Heinzlmeir, S; Helm, D; Huenges, J; Jeremias, I; Kayser, G; Klaeger, S; Koch, H; Koenig, PA; Kramer, K; Kuster, B; Médard, G; Meng, C; Petzoldt, S; Polzer, H; Preissner, R; Qiao, H; Reinecke, M; Reiter, K; Rueckert, L; Ruland, J; Ruprecht, B; Schlegl, J; Schmidt, T; Schneider, S; Schoof, M; Spiekermann, K; Tõnisson, N; Vick, B; Vooder, T; Walch, A; Wilhelm, M; Wu, Z; Zecha, J; Zolg, DP | 1 |
Bodo, J; Durkin, L; Hsi, ED | 1 |
Andreeff, M; Burks, JK; Jiffar, T; Konopleva, M; Kornblau, S; Ruvolo, PP; Ruvolo, VR; Watt, JC; Zhou, L | 1 |
3 other study(ies) available for enzastaurin and Leukemia, Myeloid, Acute
Article | Year |
---|---|
The target landscape of clinical kinase drugs.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytokines; Drug Discovery; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Mice; Molecular Targeted Therapy; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proteomics; Xenograft Model Antitumor Assays | 2017 |
Quantitative in situ detection of phosphoproteins in fixed tissues using quantum dot technology.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Calibration; Cell Line; Colonic Neoplasms; Fixatives; fms-Like Tyrosine Kinase 3; Formaldehyde; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Leukemia, Myeloid, Acute; Mice; Mutation; Neoplasm Transplantation; Phosphoproteins; Phosphorylation; Quantum Dots; STAT5 Transcription Factor; Tissue Array Analysis; Tissue Fixation; Transplantation, Heterologous | 2009 |
Targeting PKC-mediated signal transduction pathways using enzastaurin to promote apoptosis in acute myeloid leukemia-derived cell lines and blast cells.
Topics: Antigens, CD34; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Electrophoresis, Gel, Two-Dimensional; HL-60 Cells; Humans; Indoles; Leukemia, Myeloid, Acute; Microscopy, Fluorescence; Phosphorylation; Protein Kinase C; Protein Kinase C beta; Signal Transduction | 2011 |